MI-CP079 Phase II Randomized Double-Blind Multicenter Trial of Subcutaneous Amifostine (Ethyol) Versus Placebo in the Prevention of Radiochemotherapy-Induced Esophagitis and Pneumonitis in Patients with Unresctable Non-Small Cell Lung Cancer

Detalles del proyecto

EstadoFinalizado
Fecha de inicio/Fecha fin3/1/049/30/06

Financiación

  • MedImmune Inc: 2.500,00 US$